Join the CEOs of IBM, Novartis, AstraZeneca, Schering-Plough and Merck for an unrivaled perspective on the newest medical cancer technologies and the financial drivers behind those innovations at Cleveland Clinic’s 2009 Medical Innovation Summit from Oct. 5 to 7 at Cleveland’s InterContinental Hotel & Bank of America Conference Center.
2009′s summit, called Improving the Prognosis: Cancer Cures Through Innovation, will provide unparalleled insight into the newest innovations in cancer therapeutics, diagnostics and disease management systems. As medical innovation is on the threshold of an exciting new era, the pace of innovation is accelerating and physicians and companies are converging on the same solution, from different vantage points. Industry segments are consolidating, leading to the application of new technology across clinical specialties and industry segments. As a result of these changes, the approach to managing medical innovation from the business as well as the clinical side is changing.
Physicians bringing breakthrough products to market will present interactive panel sessions on the latest medical innovations; CEOs from medical innovation companies will provide an in-depth, personal look at the innovation process; and surgeons from the Cleveland Clinic Taussig Cancer Institute will perform leading-edge surgeries, featuring the latest in oncology innovations.
The event culminates with Dr. Michael Roizen’s live announcement of the Top 10 Medical Innovations for 2010, scheduled to take place at 11:15 am on Oct. 7.
“The Cleveland Clinic is an important innovator in the global healthcare system,” says Fred Hassan, chairman and CEO of Schering-Plough. “This Summit is of special importance at a time when all stakeholders are urgently engaged in efforts to improve quality, success, choice and innovation in healthcare.”
Attendee can register until 11:59PM EST via the conference Web site, otherwise, on-site registration is available beginning at 11am on Monday, October 5th.